HK Stock MarketDetailed Quotes

02216 BRONCUS-B

Watchlist
  • 0.570
  • +0.010+1.79%
Market Closed Jul 12 16:08 CST
300.50MMarket Cap-1370P/E (TTM)

About BRONCUS-B Company

Our vision: To be a global leader in lung disease treatment transformation. Our mission: To establish interventional solutions as the gold standard for lung disease treatment. Declaring war on lung cancer and chronic obstructive pulmonary disease, we are pioneers in the field of interventional respiratory medicine, providing innovative lung disease solutions in China and around the world. In the large-scale, undeveloped, and rapidly growing interventional pulmonology market, with the support of China's first and only real-time image of the whole lung arriving with navigation technology, we have established a three-in-one comprehensive interventional respiratory disease treatment platform to address the pain points of existing diagnosis and treatment models and the clinical needs of lung diseases that are far from being met, lead a paradigm shift in diagnosis and treatment, and push the field of lung disease into the era of precise diagnosis and treatment.

Company Profile

Symbol02216
Company NameBRONCUS-B
ISINKYG1609T1022
Listing DateSep 24, 2021
Issue Price18.70
Shares Offered89.36M share(s)
FoundedApr 30, 2012
Registered AddressCayman Islands
Chairmanhong xu
Secretaryjiaen sun
Audit InstitutionErnst & Young
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficePO Box 309, Ugland House Grand Cayman, KY1-1104 Cayman Islands
Head Office and Principal Place of Business40th Floor, Dah Sing Financial Centre, 248 Queen's Road East, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees308
MarketHong Kong motherboard
Phone(0571)86595016
Fax86 0571-8796 9085
Emailir@broncuschina.com
Business Kumbo Medical Holdings Co., Ltd. is a Chinese investment holding company that provides innovative lung disease solutions. The company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions, and navigation platforms. Diagnostic solution products include FlexNeedles, ATV sheaths, and ATV balloons. Lung cancer treatment solution products include Intervapor and H-Marker for lung cancer. COPD Solution products include InterVapor and targeted pulmonary denervation systems for COPD. Navigation platform products include Lungpoint, Lungpro, and next-generation navigation systems.

Company Executives

  • Name
  • Position
  • Salary
  • hong xu
  • Chairman,CEOs,Executive Director,Technical Director,Chairman of the Nomination Committee,Authorized Representative
  • --
  • ao zhang
  • Non-executive directors
  • --
  • yanhong kuang
  • Non-executive directors,Remuneration Committee Members
  • --
  • David Scott Lim
  • Independent Non-Executive Director,Audit Committee Members,Nomination Committee Members
  • --
  • bowen gan
  • Independent Non-Executive Director,Chairman of the Audit Committee,Remuneration Committee Members
  • --
  • jiaen sun
  • Authorized Representative,Company Secretary
  • --
  • yiqian huang
  • Independent Non-Executive Director,Remuneration Committee Chairman,Audit Committee Members,Nomination Committee Members
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg